Research map: Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV

Back to the article

Papers in this map

  1. A global reference for human genetic variation · Corresponding authors · 2015 · 20479 citations · Cited by this paper
  2. How to implement pre-emptive pharmacogenetic testing in the acute hospital setting · 2025 · Related
  3. Second-generation PLINK: rising to the challenge of larger and richer datasets · Christopher C. Chang · 2015 · 14473 citations · Cited by this paper
  4. Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe · 2025 · Related
  5. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations · Amit V. Khera · 2018 · 3194 citations · Cited by this paper
  6. ADIPOQ genotypes and haplotypes, circulating adiponectin levels and responsiveness to antihypertensive therapy in preeclampsia · 2025 · Related
  7. The UCSC Genome Browser Database: update 2006 · Angie S. Hinrichs · 2005 · 1847 citations · Cited by this paper
  8. UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients · 2025 · Related
  9. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes · Nasim Mavaddat · 2018 · 1214 citations · Cited by this paper
  10. Pharmacogenomic testing for Prader-Willi syndrome: a mixed methods analysis of caregiver experiences and utilization · 2025 · Related
  11. Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients · Daniel Stephan Pratt · 2000 · 1212 citations · Cited by this paper
  12. Pharmacogenomics of anthracycline-cyclophosphamide-taxane chemotherapy: an influence of CYP polymorphisms and BMI on breast cancer treatment outcomes · 2025 · Related
  13. Million Veteran Program: A mega-biobank to study genetic influences on health and disease · John Michael Gaziano · 2015 · 1157 citations · Cited by this paper
  14. Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis · 2025 · Related
  15. Improving polygenic prediction in ancestrally diverse populations · Yunfeng Ruan · 2022 · 734 citations · Cited by this paper
  16. Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine · 2026 · Related
  17. Class-Sparing Regimens for Initial Treatment of HIV-1 Infection · Sharon A. Riddler · 2008 · 682 citations · Cited by this paper
  18. Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use · 2026 · Related
  19. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks · Paul Edward Sax · 2012 · 445 citations · Cited by this paper
  20. Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies · Nilanjan Chatterjee · 2013 · 400 citations · Cited by this paper
  21. Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection · Gregory K. Robbins · 2003 · 355 citations · Cited by this paper
  22. Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1 · Eric S. Daar · 2011 · 313 citations · Cited by this paper
  23. Increasing burden of liver disease in patients with HIV infection · Deepak Man Joshi · 2011 · 308 citations · Cited by this paper
  24. Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1 · Jeffrey L. Lennox · 2014 · 264 citations · Cited by this paper
  25. Brief Report · Sharon Lynn Walmsley · 2015 · 229 citations · Cited by this paper
  26. Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 Infection A Randomized Controlled Trial · Roy M. Gulick · 2006 · 222 citations · Cited by this paper
  27. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation · Marijana Vujković · 2022 · 202 citations · Cited by this paper
  28. The Genetic Architecture of Liver Enzyme Levels: GGT, ALT and AST · Jenny H. D. A. van Beek · 2013 · 189 citations · Cited by this paper
  29. Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV ‐1‐infected treatment‐naïve patients in the ARTEMIS trial · Chloe M. Orkin · 2012 · 159 citations · Cited by this paper
  30. Mechanisms of liver disease in patients infected with HIV · Matthew B Kaspar · 2017 · 148 citations · Cited by this paper
  31. HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms · Stanislas Pol · 2004 · 135 citations · Cited by this paper
  32. How much missing data is too much to impute for longitudinal health indicators? A preliminary guideline for the choice of the extent of missing proportion to impute with multiple imputation by chained equations · K. P. Junaid · 2025 · 81 citations · Cited by this paper
  33. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era · Jennifer R. Kramer · 2004 · 77 citations · Cited by this paper
  34. Prevalence and Factors Associated With Liver Test Abnormalities Among Human Immunodeficiency Virus–Infected Persons · Nancy F. Crum‐Cianflone · 2009 · 77 citations · Cited by this paper
  35. Epidemiology and Genetic Epidemiology of the Liver Function Test Proteins · Nilüfer Rahmioğlu · 2009 · 68 citations · Cited by this paper
  36. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes · Sara L. Pulit · 2018 · 54 citations · Cited by this paper
  37. Application and impact of Lasso regression in gastroenterology: A systematic review · Hassam Ali · 2023 · 48 citations · Cited by this paper
  38. Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data · Nisreen S. Husain · 2014 · 46 citations · Cited by this paper
  39. A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome · Mark Wayne Sonderup · 2015 · 43 citations · Cited by this paper

Source: OpenAlex (CC0)